Skip to Content

Northwest CCOP

The Northwest Clinical Community Oncology Program (NW CCOP) has been in existence since the inception of the NCI's Clinical Community Oncology Program in 1983. As one of the founding CCOPs, the NW CCOP plays an integral role in achieving the NCI's objective of connecting community cancer specialists and primary care providers with NCI sponsored clinical trials. The NW CCOP is an experienced consortium of hospitals and independent oncology practices spanning three states serving local communities within western Washington, northern Oregon and northern Idaho.

The overall purpose of the NW CCOP is to bring clinical advances through the most cutting edge research protocols to local communities. NW CCOP utilizes the Clinical Trials Support Unit (CTSU) as well as the Southwest Oncology Group (SWOG), National Surgical Adjuvant Breast and Bowel Project (NSABP), University of Rochester Cancer Center (URCC), M.D. Anderson Cancer Center (MDACC), and the Sun Coast CCOP Research Bases. The NW CCOP provides community oncologists with the opportunity to participate in a variety of treatment and cancer prevention and control research trials provided by these research bases.

The specific aims of the NW CCOP are to:

  • Increase patients' access within Washington, Idaho, and Oregon to advances in treatment and cancer control and prevention clinical trials within their local communities;
  • Expand outreach efforts to minority and underserved populations;
  • Increase the knowledge, awareness, and involvement of the primary healthcare providers to promote increased participation in cancer treatment, and cancer control and prevention trials; and
  • Provide enhanced systems supporting the consortium through communication and training among providers and coordinators thereby promoting quality and timely data collection while maintaining a level of excellence in protection of study participants.

For the past three decades, the NW CCOP has contributed to the body of knowledge and advancements of cancer treatments. The NW CCOP continues to support the investigation of a variety of chemotherapy agents, from being investigational agents to FDA approved products for a host of indications. Since 1983, we have contributed to significant medical advances especially in the adjuvant treatment settings.

Catchment area

  • MultiCare Health System
    Tacoma, Gig Harbor and Auburn, WA
  • Kaiser Permanente Northwest Region
    Portland, OR
  • Northwest Medical Specialties
    Tacoma, Gig Harbor and Puyallup, WA
  • Providence Western Washington Oncology
    Lacey, WA
  • Providence Regional Cancer Partnership
    Everett, WA
  • Capital Oncology
    Olympia, WA
  • St. Joseph Regional Medical Center
    Lewiston, ID
  • Overlake Hospital Medical Center
    Bellevue, WA

Top

MultiCare logo

  • Principal Investigator
    John Keech, MD
  • Northwest CCOP
    315 Martin Luther King Jr. Way
    Tacoma, WA 98405
    Phone: (253) 403-1461
    Fax: (253) 403-1615
  • Administrator
    Karyn Hart, CCRP
    karyn.hart@multicare.org

    View Website Exit Disclaimer
  • State(s) Served
    Western Washington, Northern Oregon, Northern Idaho